ProMIS Neurosciences(PMN)
$3.29-0.19 (-5.46%)
PMN
ProMIS Neurosciences financials statements
$3.29
At close:-0.19 (-5.46%)
Want to see PMN full AI Analyst Report?
ProMIS Neurosciences (PMN) Ratios
312 Followers
ProMIS Neurosciences Ratios
PMN's free cash flow for Q3 2026 was C$-9.38M. For the 2026 fiscal year, PMN's free cash flow was increased by C$0.00 and operating cash flow was C$-9.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.88 | 8.52 | 1.46 | 1.08 | 19.07 |
| Quick Ratio | 0.88 | 8.52 | 1.46 | 1.08 | 19.07 |
| Cash Ratio | 0.59 | 5.99 | 1.35 | 0.92 | 18.24 |
| Solvency Ratio | -3.80 | 1.15 | -1.77 | -1.61 | -0.63 |
| Operating Cash Flow Ratio | -2.70 | -12.25 | -1.16 | -1.96 | -8.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | C$ -1.26M | C$ 16.49M | C$ 3.75M | C$ -1.85M | C$ 7.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.69 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 |
| Financial Leverage Ratio | -7.30 | 1.15 | 3.63 | -5.14 | 3.14 |
| Debt Service Coverage Ratio | 0.00 | 37.20 | -88.43 | -63.00 | -23.40 |
| Interest Coverage Ratio | 0.00 | -219.18 | -93.84 | -82.89 | -19.82 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Interest Debt Per Share | 0.00 | 0.07 | 0.41 | 0.94 | 23.14 |
| Net Debt to EBITDA | 0.15 | -4.65 | 0.71 | 0.45 | 1.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -71796.88% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | -115175.95% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | -114612.90% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -101363.57% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -113562.83% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -118662.24% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -120290.84% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 104.49% |
| EBT Per EBIT | 98.88% | -16.51% | 92.64% | 77.26% | 112.04% |
| Return on Assets (ROA) | -432.56% | 14.69% | -128.54% | -192.65% | -43.03% |
| Return on Equity (ROE) | 3155.84% | 16.85% | -466.42% | 989.81% | -134.93% |
| Return on Capital Employed (ROCE) | 3267.20% | -100.81% | -442.62% | -3375.26% | -38.79% |
| Return on Invested Capital (ROIC) | 3267.20% | -100.81% | -442.62% | -3375.26% | -38.79% |
| Return on Tangible Assets | -432.56% | 14.69% | -128.54% | -193.23% | -43.10% |
| Earnings Yield | -331.01% | 11.31% | -123.84% | -55.47% | -20.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 1.33 | 0.00 | 11.31 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 1.38 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -274.08 | 0.00 | -32.26 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 274.08 | 0.00 | 32.26 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -16.01 | -26.22 | -22.05 | -56.76 | -40.80 |
| Free Cash Flow Per Share | -16.01 | -26.22 | -22.05 | -56.77 | -40.83 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -8598.63 | -1541.61 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -8598.63 | -1541.61 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -1.91 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -1160.18 |
| Free Cash Flow Yield | -234.34% | -110.62% | -76.71% | -52.32% | -19.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.30 | 8.62 | -0.81 | -1.80 | -5.00 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 5930.63 |
| Price-to-Book (P/B) Ratio | -9.53 | 1.49 | 3.77 | -17.84 | 6.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.43 | -0.90 | -1.30 | -1.91 | -5.11 |
| Price-to-Operating Cash Flow Ratio | -0.43 | -0.90 | -1.30 | -1.91 | -5.11 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.08 | 0.05 | -1.00 | -0.06 |
| Enterprise Value Multiple | -0.15 | 3.95 | -0.09 | -1.38 | -3.41 |
| Enterprise Value | 5.88M | 11.28M | 1.54M | 24.61M | 31.78M |
| EV to EBITDA | -0.15 | 3.95 | -0.09 | -1.38 | -3.41 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 3904.91 |
| EV to Free Cash Flow | -0.21 | -0.42 | -0.14 | -1.44 | -3.36 |
| EV to Operating Cash Flow | -0.21 | -0.42 | -0.14 | -1.44 | -3.37 |
| Tangible Book Value Per Share | -0.72 | 15.90 | 7.63 | -6.17 | 30.78 |
| Shareholders’ Equity Per Share | -0.72 | 15.90 | 7.63 | -6.08 | 30.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Net Income Per Share | -22.61 | 2.68 | -35.60 | -60.19 | -41.73 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.04 |
| Interest Burden | 1.00 | 0.97 | 0.98 | 1.02 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 608.10 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 407.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.71 | -9.78 | 0.82 | 0.94 | 1.00 |
Currency in CAD

